Arabinogalactan-Functionalized Gold Nanoparticles Demonstrated Remarkable Anticancer Therapeutic Effect against Hepatocellular Carcinoma
Molecular Pharmaceutics · 2025
DOI: 10.1021/acs.molpharmaceut.5c00598 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Vasumathi R und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Manipal College of Health Professions, Manipal Academy of Higher Education (MAHE), Manipal 576104, Karnataka, India. Hauptthemen laut MEDLINE: Gold, Galactans, Metal Nanoparticles, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Indian Council of Medical Research.
Abstract (Originalsprache)
The treatment and prognosis of cancer remain highly challenging due to its complex and multifaceted nature. In the paradigm of nanomedicine, nanotechnology has gained huge attention in cancer therapeutics. The unique physicochemical properties offered by gold nanoparticles (AuNPs) in targeted drug delivery and anticancer therapy favor their implications in cancer therapeutics. However, surface modification, particularly with polysaccharides, can further optimize the function of gold nanoparticles. Among others, the advantages offered by arabinogalactan (AG) make it a suitable candidate for coating gold nanoparticles. The present study reported the anticancer therapeutic potential of AG-AuNPs against liver cancer. The synthesized AG-AuNPs were characterized for UV-visible spectrum, hydrodynamic size, zeta potential, core size, bonding and functional groups, crystalline nature, and elemental composition. The compound was then evaluated for its stability in biological fluids followed by in vivo biodistribution and anticancer therapeutic potential in rodent model of hepatocellular carcinoma (HCC). The chemical characterization of AG-AuNPs revealed a successful coating of AG onto AuNPs. The nanoparticles were stable in serum for up to 24 h with no appreciable change in the size of the UV-visible spectrum. The in vivo biodistribution study demonstrated excellent selective accumulation of AG-AuNPs in liver tumors with 1.6 times higher uptake as compared to nontumor liver tissue. AG-AuNPs showed a significantly decreased tumor load and restoration of tissue histoarchitecture in the treatment group as compared to the untreated tumor group. Overall, this study suggested that AG-AuNPs demonstrated a good anticancer therapeutic effect for the targeted treatment of HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Manipal College of Health Professions, Manipal Academy of Higher Education (MAHE), Manipal 576104, Karnataka, India.
- Department of Biochemistry, Kasturba Medical College, Manipal Academy of higher education, Manipal Academy of Higher Education (MAHE), Manipal 576104, Karnataka, India.
- Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education (MAHE), Manipal 576104, Karnataka, India.
ORCID-Profile: Srinivas Mutalik, Sanjay Bharati
Förderung
- Indian Council of Medical Research
Zitieren
APA
R, V., Shetty, M. P., S, S., Shenoy, R. P., Mutalik, S., & Bharati, S. (2025). Arabinogalactan-Functionalized Gold Nanoparticles Demonstrated Remarkable Anticancer Therapeutic Effect against Hepatocellular Carcinoma. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c00598
Vancouver
R V, Shetty MP, S S, Shenoy RP, Mutalik S, Bharati S. Arabinogalactan-Functionalized Gold Nanoparticles Demonstrated Remarkable Anticancer Therapeutic Effect against Hepatocellular Carcinoma. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.5c00598
BibTeX
@article{R2025,
author = {R, Vasumathi and Shetty, Maya P and S, Suvalakshmi and Shenoy, Revathi P and Mutalik, Srinivas and Bharati, Sanjay},
title = {Arabinogalactan-Functionalized Gold Nanoparticles Demonstrated Remarkable Anticancer Therapeutic Effect against Hepatocellular Carcinoma},
journal = {Molecular Pharmaceutics},
year = {2025},
doi = {10.1021/acs.molpharmaceut.5c00598}
}
EUVIMED